Spark Therapeutics (ONCE) PT Raised to $101 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Matthew Luchini raised his price target on Spark Therapeutics (NASDAQ: ONCE) to $101.00 (from $89.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
